U2AF1 and myelodysplastic syndrome: Considering that U2AF1 mutations are reported in ∼10% of patients with MDS and associated with partial functional impairment in regulated splicing2, 19, we tested two MDS samples each harbouring one of the two U2AF1 hotspot mutations, S34F and Q157P.